Home
Stock
STAB
News

NASDAQ: FCUV 33.41%

Focus Universal (FCUV) Reveals Further Aspects to Proprietary Deterministic AI Technologies - A New Class of Artificial Intelligence Designed for Certainty, Compliance, and Execution

NASDAQ: HELP 18.34%

MissionIRNewsBreaks - Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Closes $50 Million Public Offering

NASDAQ: ERNA 18.91%

Ernexa Therapeutics Highlights Ovarian Cancer Unmet Need, Hope for Patients and Potential Accessibility Advantages of ERNA-101 in Virtual Investor KOL Connect Segment Featuring Dr. Ira Winer

OTC: FSRL 19.33%

First Reliance Bancshares Reports First Quarter 2026 Results

NASDAQ: ILLR 330.86%

Triller Group's subsidiary - AGBA announce a transformative step forward

NASDAQ: MUU 30.78%

US Companies Moving the Markets, Evening edition
Thu, Jun 25, 2026 as of 4:00 pm ET

NASDAQ: FCUV 18.34%

Focus Universal (FCUV) Reveals Further Aspects to Proprietary Deterministic AI Technologies - A New Class of Artificial Intelligence Designed for Certainty, Compliance, and Execution

NASDAQ: HELP 18.34%

MissionIRNewsBreaks - Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Closes $50 Million Public Offering

NASDAQ: ERNA 18.34%

Ernexa Therapeutics Highlights Ovarian Cancer Unmet Need, Hope for Patients and Potential Accessibility Advantages of ERNA-101 in Virtual Investor KOL Connect Segment Featuring Dr. Ira Winer

NASDAQ: FSRL 18.34%

First Reliance Bancshares Reports First Quarter 2026 Results

NASDAQ: ILLR 18.34%

Triller Group's subsidiary - AGBA announce a transformative step forward

NASDAQ: MUU 18.34%

US Companies Moving the Markets, Evening edition
Thu, Jun 25, 2026 as of 4:00 pm ET

STAB

Quote

Short

News

Articles

Message Board

Statera Biopharma Inc. (OTCMKTS : STAB ) News

News Releases

STAB News Releases

February 12, 2025 10:40:00 am

STAB : OTC

AllPennyStocks.com

Shares Of Micro Cap Biotech Surging On Acquisition Of Exclusive Worldwide Rights to Phase III TLR5 Agonist

February 12, 2025 09:34:07 am

STAB : OTC

24/7 Market News

Tivic Health Acquires Exclusive Worldwide Rights to Statera Biopharma's Phase III TLR5 Agonist

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Email address

Mobile

I accept the terms of service

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.

Trending Stocks

Disclaimer:
This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a any stock financial position. any stock's financial position and all other information regarding the featured Company should be verified directly with any stock. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in any company is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of any stock's shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Please read our full disclaimer for compensation and more detailed information.

Advertise

Brand your company, advertise your products or services with our brand awareness programs.

Advertise

Tokenization & Crypto Exchange

Tokenization & Crypto Exchange solutions for OTC Markets and TSX Venture issuers. Issue compliant Security Tokens alongside existing shares, list on international exchanges

Tokenization & Crypto Exchange

Research

About
Stock Search
News Releases
Articles
Message Boards
Short Information
Top Gainers
Trending Stocks
Trending Feed
Sitemap

Legal

Terms of Service
Privacy Policy
Disclaimer

Links

RSS feed
Facebook
X
LinkedIn
BlueSky
Telegram
Discord
Reddit
Add to Google News

A leading stock news platform for real‑time stock market news, press releases, articles, and tools for trading and investing.

Information only — not investment advice.